Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03552822 · ClinicalTrials.gov registry record
Cesarean Section Via Enhanced Recovery
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 541
- Enrollment target
NCT03552822 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 541 participants.
The verdict
NCT03552822 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 541 participants
- Enrollment target
Study Summary
Enhanced Recovery After Surgery (ERAS) protocols have been proven to be very successful in specific patient populations. An example is with ERAS for colorectal surgery. ERAS protocols in this patient population have been shown to reduce overall morbidity and hospital length of stay (LOS). At the University of Alabama at Birmingham (UAB), the institution has had successful implementation of ERAS protocols for several surgical specialties including colorectal, breast, spine, gynecology, and gynecology-oncology. However, the institution currently does not have a protocol in place for the most commonly performed surgical procedure - cesarean delivery. At UAB, the institution performs approximately 1,000 cesarean deliveries per year. The investigators believe that an ERAS protocol will be beneficial for these patients. Currently, there is very little data published on ERAS protocols. Although this patient population is ideal for an ERAS protocol, there are several barriers that have to be overcome. The data published show promising results for ERAS protocols with cesarean delivery. A larger tertiary care center showed earlier discharge with lower re-admission rates with an ERAS pathway. Currently, the investigators have created a multidisciplinary group at UAB to establish an ERAS protocol for patients undergoing cesarean delivery. This group includes anesthesiologists, obstetricians, nursing, neonatology, pharmacy, and informatics. Once the investigators have implemented this protocol, the investigators would like to perform a retrospective analysis to determine if there are any significant changes in our desired outcomes the investigators will study. Our goal is to demonstrate significantly improved outcomes in the investigators' measured endpoints. The investigators believe that this information will be very useful because although there is a national interest in creating ERAS protocols for cesarean deliveries, there currently is very little published on the subject
Interventions
- OTHER ERAS Protocol Implementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03552822
The ClinicalTrials.gov registry entry for NCT03552822 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 541 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ERAS Protocol Implementation is the first listed.
NCT03552822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03552822 about?
NCT03552822 is a clinical study titled "Cesarean Section Via Enhanced Recovery". Enhanced Recovery After Surgery (ERAS) protocols have been proven to be very successful in specific patient populations. An example is with ERAS for colorectal surgery. ERAS protocols in this patient population have been shown to reduce overall morbidity and hospital length of stay (LOS). At the Uni...
What is the current status of trial NCT03552822?
This trial is currently completed. The enrollment target is 541 participants. The study started on 2018-07-01. Estimated completion is 2020-02-01.
What interventions are being tested in trial NCT03552822?
The interventions under investigation include: ERAS Protocol Implementation (OTHER).
Who is sponsoring clinical trial NCT03552822?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.